NCT05669729View on ClinicalTrials.gov

A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2026

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Gaucher Disease
Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY